BioSpace News Archive

Genetown

Kernal Biologics to Present at 3rd Annual mRNA-Based Therapeutics Summit

Kernal Biologics, Inc. today announced it is presenting in person at the 3rd Annual mRNA-Based Therapeutics Summit in Boston, MA.

July 20, 2023
·
2 min read
BioMidwest

MediView Receives FDA 510(k) Clearance for XR90 Augmented Reality-Based Visualization and Navigation Platform

MediView XR, Inc., a leading clinical augmented reality med-tech company, announced today it received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) for its XR90 augmented reality-based surgical visualization and navigation platform.

July 20, 2023
·
4 min read
Deals

Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Spectrum Pharmaceuticals Stockholders Vote “FOR” Proposed Transaction with Assertio Holdings, Inc.

Spectrum Pharmaceuticals, Inc. have each recommended that Spectrum stockholders vote “FOR” the proposal to adopt the Agreement and Plan of Merger (“Merger Agreement”, and such proposal, the “Merger Proposal”) at the upcoming special meeting of stockholders (the “Special Meeting”) on July 27, 2023.

July 20, 2023
·
9 min read
Business

The Silverstein Foundation Launches Post-Doctoral Fellowship Program to Fund Novel Research for Parkinson’s Disease in GBA Mutation Carriers

The Silverstein Foundation for Parkinson’s with GBA (“Silverstein Foundation”) today announced the creation of a two-year, post-doctoral fellowship program that will fund eleven scientists engaged in cutting-edge research on Parkinson’s disease in GBA mutation carriers (GBA-PD) in academic and hospital-based laboratories around the world.

July 20, 2023
·
2 min read
Business

BioSig AI Sciences Selected for NVIDIA Inception Partnership Program to Support R&D Collaboration on AI Medical Device Platform for Hospitals

BioSig Technologies, Inc. today announced that its subsidiary BioSig AI Sciences, Inc. (BAIS) was selected to join NVIDIA Inception, a program designed to partner with companies revolutionizing industries with advancements in artificial intelligence (AI) and data sciences.

July 20, 2023
·
4 min read
Business

Arbutus to Report Second Quarter 2023 Financial Results and Provide Corporate Update

Arbutus Biopharma Corporation today announced that it has scheduled its second quarter 2023 financial results and corporate update for Thursday, August 3, 2023.

July 20, 2023
·
1 min read
FDA

Advent Therapeutics Receives FDA Rare Pediatric Disease Designation for Retinol Palmitate for Prevention of Bronchopulmonary Dysplasia in Premature Infants

Advent Therapeutics, Inc. announced today that it has received U.S. Food and Drug Administration (FDA) Rare Pediatric Disease Designation (RPDD) for its vitamin A metabolic and reparative respiratory drugs for the prevention of Bronchopulmonary Dysplasia (BPD) in premature infants.

July 20, 2023
·
3 min read
Business

Abbott Reports Second-Quarter 2023 Results; Increases Outlook For Underlying Base Business

Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2023.

July 20, 2023
·
28 min read
Business

Endo Announces First Patient Enrolled in Registry of Peyronie’s Disease

Endo International plc (OTC: ENDPQ) announced today that the first patient has been enrolled in CURVE-PD (Clinical Understanding through Real-world data to Validate Effectiveness of treatments in Peyronie’s disease), a non-interventional registry of up to 1,000 patients with Peyronie’s disease (PD).

July 20, 2023
·
7 min read
Business

Agenus Expands Executive Leadership Team

Immuno-oncology leader, Agenus Inc. (“Agenus”) (Nasdaq: AGEN), today announced the appointment of Robin Taylor, Ph.D., Homa Yeganegi and Stephanie Fagan to its executive team.

July 20, 2023
·
9 min read